My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes.

    Alyanakian MA, Grela F, Aumeunier A, Chiavaroli C, Gouarin C, Bardel E, Normier G, Chatenoud L, Thieblemont N, Bach JF.

    Diabetes. 2006 Jan;55(1):179-85.PMID: 16380491 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells.

    Mi QS, Ly D, Zucker P, McGarry M, Delovitch TL.

    Diabetes. 2004 May;53(5):1303-10.PMID: 15111500 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Endogenous transforming growth factor-beta inhibits toll-like receptor mediated activation of human uterine natural killer cells.

    Eriksson M, Meadows SK, Wira CR, Sentman CL.

    Am J Reprod Immunol. 2006 Nov-Dec;56(5-6):321-8.PMID: 17076676 [PubMed - indexed for MEDLINE]Related articles

    4.

    Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.

    Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K.

    Int Immunol. 2007 Mar;19(3):311-20. Epub 2007 Feb 7.PMID: 17289654 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta.

    Terabe M, Khanna C, Bose S, Melchionda F, Mendoza A, Mackall CL, Helman LJ, Berzofsky JA.

    Cancer Res. 2006 Apr 1;66(7):3869-75.PMID: 16585215 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses.

    Harada M, Magara-Koyanagi K, Watarai H, Nagata Y, Ishii Y, Kojo S, Horiguchi S, Okamoto Y, Nakayama T, Suzuki N, Yeh WC, Akira S, Kitamura H, Ohara O, Seino K, Taniguchi M.

    J Exp Med. 2006 Dec 25;203(13):2929-37. Epub 2006 Dec 18.PMID: 17178921 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.

    Kim S, Kim HS, Chung KW, Oh SH, Yun JW, Im SH, Lee MK, Kim KW, Lee MS.

    Diabetes. 2007 Oct;56(10):2561-8. Epub 2007 Jul 9.PMID: 17620422 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.

    Hise AG, Daehnel K, Gillette-Ferguson I, Cho E, McGarry HF, Taylor MJ, Golenbock DT, Fitzgerald KA, Kazura JW, Pearlman E.

    J Immunol. 2007 Jan 15;178(2):1068-76.PMID: 17202370 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma.

    Laouar Y, Sutterwala FS, Gorelik L, Flavell RA.

    Nat Immunol. 2005 Jun;6(6):600-7. Epub 2005 Apr 24.PMID: 15852008 [PubMed - indexed for MEDLINE]Related articles

    10.

    Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta.

    Richer MJ, Straka N, Fang D, Shanina I, Horwitz MS.

    Diabetes. 2008 May;57(5):1302-11. Epub 2008 Feb 11.PMID: 18268045 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.

    Rad R, Brenner L, Krug A, Voland P, Mages J, Lang R, Schwendy S, Reindl W, Dossumbekova A, Ballhorn W, Wagner H, Schmid RM, Bauer S, Prinz C.

    Gastroenterology. 2007 Jul;133(1):150-163.e3. Epub 2007 May 3.PMID: 17631139 [PubMed - indexed for MEDLINE]Related articles

    12.

    Induction of active tolerance and involvement of CD1d-restricted natural killer T cells in anti-CD3 F(ab')2 treatment-reversed new-onset diabetes in nonobese diabetic mice.

    Chen G, Han G, Wang J, Wang R, Xu R, Shen B, Qian J, Li Y.

    Am J Pathol. 2008 Apr;172(4):972-9. Epub 2008 Mar 18.PMID: 18349126 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes.

    You S, Thieblemont N, Alyanakian MA, Bach JF, Chatenoud L.

    Immunol Rev. 2006 Aug;212:185-202. Review.PMID: 16903915 [PubMed - indexed for MEDLINE]Related articles

    14.

    MyD88-dependent responses involving toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires' disease.

    Archer KA, Roy CR.

    Infect Immun. 2006 Jun;74(6):3325-33.PMID: 16714560 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.

    Bobacz K, Sunk IG, Hofstaetter JG, Amoyo L, Toma CD, Akira S, Weichhart T, Saemann M, Smolen JS.

    Arthritis Rheum. 2007 Jun;56(6):1880-93.PMID: 17530716 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    MyD88-dependent IFN-gamma production by NK cells is key for control of Legionella pneumophila infection.

    Spörri R, Joller N, Albers U, Hilbi H, Oxenius A.

    J Immunol. 2006 May 15;176(10):6162-71.PMID: 16670325 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.

    Xu H, An H, Hou J, Han C, Wang P, Yu Y, Cao X.

    Mol Immunol. 2008 Aug;45(13):3545-52. Epub 2008 Jun 20.PMID: 18571728 [PubMed - indexed for MEDLINE]Related articles

    18.

    Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo.

    Warger T, Osterloh P, Rechtsteiner G, Fassbender M, Heib V, Schmid B, Schmitt E, Schild H, Radsak MP.

    Blood. 2006 Jul 15;108(2):544-50. Epub 2006 Mar 14.PMID: 16537810 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

    Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E, Szabo G.

    Hepatology. 2008 Oct;48(4):1224-31.PMID: 18792393 [PubMed - indexed for MEDLINE]Related articles

    20.

    Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection.

    McKay D, Shigeoka A, Rubinstein M, Surh C, Sprent J.

    Eur J Immunol. 2006 Aug;36(8):1994-2002.PMID: 16874736 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity